Biotechnology
The Biotechnology industry has a total of 616 stocks, with a combined market cap of $986.18 billion and total revenue of $101.07 billion.
Market Cap
986.18B
Revenue
101.07B
Profits
-42.63B
PE Ratio
n/a
Profit Margin
-42.18%
Dividend Yield
0.04%
616 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 104.55B | - | 271,740 | 11.42B |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 61.87B | 2.51% | 469,221 | 2.46B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 57.52B | -1.76% | 696,141 | 14.21B |
| 4 | ARGX | argenx SE | 48.76B | 1.29% | 96,874 | 3.12B |
| 5 | ONC | BeOne Medicines AG | 36.51B | 3.60% | 82,738 | 4.56B |
| 6 | INSM | Insmed Incorporated | 35.05B | 2.15% | 807,631 | 398.11M |
| 7 | BNTX | BioNTech SE | 24.72B | 0.74% | 1,067,485 | 3.38B |
| 8 | RPRX | Royalty Pharma plc | 20.78B | -1.06% | 643,547 | 2.31B |
| 9 | GMAB | Genmab A/S | 19.59B | 2.67% | 1,151,668 | 3.65B |
| 10 | SMMT | Summit Therapeutics Inc. | 16.86B | 6.32% | 4,102,298 | - |
| 11 | INCY | Incyte Corporation | 16.56B | 1.19% | 359,521 | 4.58B |
| 12 | ASND | Ascendis Pharma A/S | 12.99B | 1.46% | 190,369 | 576.33M |
| 13 | IONS | Ionis Pharmaceuticals, Inc. | 11.33B | 1.60% | 908,279 | 944.05M |
| 14 | ROIV | Roivant Sciences Ltd. | 11.02B | 0.62% | 1,246,347 | 23.23M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 10.71B | 0.92% | 699,866 | 235.81M |
| 16 | MRNA | Moderna, Inc. | 10.45B | -0.30% | 5,316,990 | 3.08B |
| 17 | EXEL | Exelixis, Inc. | 10.43B | 1.55% | 932,238 | 2.23B |
| 18 | BMRN | BioMarin Pharmaceutical Inc. | 10.13B | 0.82% | 747,407 | 3.06B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.58B | 0.05% | 97,128 | 515.55M |
| 20 | TECH | Bio-Techne Corporation | 9.25B | 1.24% | 646,273 | 1.22B |
| 21 | RVMD | Revolution Medicines, Inc. | 9.09B | 0.85% | 585,589 | - |
| 22 | CAI | Caris Life Sciences, Inc. | 8.73B | 1.87% | 175,793 | 533.85M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 8.16B | -0.63% | 125,357 | 4.09B |
| 24 | CORT | Corcept Therapeutics Incorporated | 7.66B | -1.77% | 543,609 | 716.08M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 7.63B | 1.76% | 604,502 | 1.18B |
| 26 | CYTK | Cytokinetics, Incorporated | 7.28B | 1.30% | 550,177 | 85.74M |
| 27 | MRUS | Merus N.V. | 7.18B | 0.40% | 1,593,912 | 56.23M |
| 28 | RNA | Avidity Biosciences, Inc. | 7.12B | -0.36% | 483,739 | 10.73M |
| 29 | ABVX | ABIVAX Société Anonyme | 6.95B | 1.49% | 647,621 | 7.07M |
| 30 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.73B | 0.45% | 199,097 | 156.29M |
| 31 | NUVL | Nuvalent, Inc. | 6.42B | 1.04% | 120,935 | - |
| 32 | CRSP | CRISPR Therapeutics AG | 6.39B | -3.79% | 1,714,409 | 38.05M |
| 33 | LEGN | Legend Biotech Corporation | 6.04B | 3.22% | 1,105,124 | 796.84M |
| 34 | AXSM | Axsome Therapeutics, Inc. | 6.03B | -0.66% | 148,570 | 495.03M |
| 35 | PCVX | Vaxcyte, Inc. | 5.84B | 2.88% | 1,078,186 | - |
| 36 | MTSR | Metsera, Inc. | 5.56B | -0.06% | 519,322 | - |
| 37 | KRYS | Krystal Biotech, Inc. | 5.35B | 1.88% | 93,083 | 359.21M |
| 38 | PTCT | PTC Therapeutics, Inc. | 5.32B | 1.16% | 409,561 | 1.76B |
| 39 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.10B | 4.12% | 803,710 | 572.98M |
| 40 | PTGX | Protagonist Therapeutics, Inc. | 5.07B | -6.32% | 3,302,951 | 209.18M |
| 41 | TGTX | TG Therapeutics, Inc. | 4.97B | 0.89% | 525,516 | 454.07M |
| 42 | ACLX | Arcellx, Inc. | 4.89B | 1.61% | 288,463 | 56.98M |
| 43 | NAMS | NewAmsterdam Pharma Company N.V. | 4.46B | 6.82% | 1,618,809 | 64.01M |
| 44 | AKRO | Akero Therapeutics, Inc. | 4.32B | 0.15% | 1,744,611 | - |
| 45 | KYMR | Kymera Therapeutics, Inc. | 4.24B | 3.76% | 290,907 | 44.71M |
| 46 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.23B | -0.04% | 406,819 | 1.39M |
| 47 | QURE | uniQure N.V. | 3.90B | 2.83% | 1,094,727 | 14.34M |
| 48 | VKTX | Viking Therapeutics, Inc. | 3.84B | 1.67% | 1,974,493 | - |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 3.69B | 1.00% | 147,120 | 429.16M |
| 50 | ZLAB | Zai Lab Limited | 3.52B | 4.71% | 176,163 | 427.80M |
| 51 | ADMA | ADMA Biologics, Inc. | 3.48B | 0.28% | 1,582,065 | 474.17M |
| 52 | SLNO | Soleno Therapeutics, Inc. | 3.41B | 0.51% | 603,990 | 32.66M |
| 53 | MLYS | Mineralys Therapeutics, Inc. | 3.39B | 3.70% | 888,775 | - |
| 54 | ACAD | ACADIA Pharmaceuticals Inc. | 3.39B | 0.02% | 932,505 | 1.02B |
| 55 | AAPG | Ascentage Pharma Group International | 3.36B | 4.32% | 2,171 | 54.52M |
| 56 | CGON | CG Oncology, Inc. | 3.31B | 0.28% | 372,616 | 551.00K |
| 57 | SRRK | Scholar Rock Holding Corporation | 3.30B | -12.92% | 8,559,672 | - |
| 58 | TLX | Telix Pharmaceuticals Limited | 3.19B | 0.31% | 63,616 | 664.23M |
| 59 | APLS | Apellis Pharmaceuticals, Inc. | 3.15B | -0.80% | 529,967 | 754.65M |
| 60 | APGE | Apogee Therapeutics, Inc. | 3.14B | 2.25% | 360,455 | - |
| 61 | XENE | Xenon Pharmaceuticals Inc. | 3.13B | 2.50% | 415,455 | 7.50M |
| 62 | RARE | Ultragenyx Pharmaceutical Inc. | 3.10B | 2.42% | 474,204 | 610.16M |
| 63 | IMVT | Immunovant, Inc. | 3.05B | 2.73% | 399,597 | - |
| 64 | CNTA | Centessa Pharmaceuticals plc | 3.05B | 1.84% | 394,890 | 15.00M |
| 65 | TARS | Tarsus Pharmaceuticals, Inc. | 2.97B | 0.41% | 286,283 | 295.52M |
| 66 | CDTX | Cidara Therapeutics, Inc. | 2.84B | -0.79% | 356,205 | 302.00K |
| 67 | NTLA | Intellia Therapeutics, Inc. | 2.63B | -0.16% | 3,463,147 | 52.86M |
| 68 | BLTE | Belite Bio, Inc | 2.61B | 0.40% | 16,775 | - |
| 69 | OCUL | Ocular Therapeutix, Inc. | 2.57B | 3.14% | 1,491,807 | 56.66M |
| 70 | FOLD | Amicus Therapeutics, Inc. | 2.55B | -0.36% | 1,573,544 | 571.16M |
| 71 | BEAM | Beam Therapeutics Inc. | 2.54B | -1.67% | 1,329,056 | 60.27M |
| 72 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.51B | 0.83% | 350,520 | 558.50M |
| 73 | IRON | Disc Medicine, Inc. | 2.46B | 1.38% | 116,642 | - |
| 74 | ARQT | Arcutis Biotherapeutics, Inc. | 2.46B | 2.19% | 769,374 | 263.47M |
| 75 | ADPT | Adaptive Biotechnologies Corporation | 2.37B | 2.64% | 761,048 | 205.22M |
| 76 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | 0.27% | 113,660 | 40.88M |
| 77 | IDYA | IDEAYA Biosciences, Inc. | 2.37B | 2.86% | 419,529 | 7.00M |
| 78 | RXRX | Recursion Pharmaceuticals, Inc. | 2.36B | 1.69% | 38,636,419 | 64.60M |
| 79 | COGT | Cogent Biosciences, Inc. | 2.35B | 3.38% | 819,464 | - |
| 80 | MESO | Mesoblast Limited | 2.35B | 0.76% | 106,770 | 17.20M |
| 81 | IBRX | ImmunityBio, Inc. | 2.34B | 5.08% | 7,101,404 | 56.60M |
| 82 | TVTX | Travere Therapeutics, Inc. | 2.34B | 4.17% | 419,671 | 333.87M |
| 83 | ETNB | 89bio, Inc. | 2.30B | -0.14% | 876,129 | - |
| 84 | GLPG | Galapagos NV | 2.25B | 0.23% | 59,782 | 323.67M |
| 85 | DNLI | Denali Therapeutics Inc. | 2.23B | -0.91% | 416,428 | - |
| 86 | SRPT | Sarepta Therapeutics, Inc. | 2.16B | -0.05% | 2,525,433 | 2.48B |
| 87 | CELC | Celcuity Inc. | 2.09B | 6.90% | 766,151 | - |
| 88 | LQDA | Liquidia Corporation | 2.06B | 3.02% | 605,958 | 19.32M |
| 89 | DYN | Dyne Therapeutics, Inc. | 2.01B | 0.50% | 658,213 | - |
| 90 | VERA | Vera Therapeutics, Inc. | 1.95B | 1.65% | 336,722 | - |
| 91 | RCUS | Arcus Biosciences, Inc. | 1.80B | 15.55% | 1,053,947 | 262.00M |
| 92 | CLDX | Celldex Therapeutics, Inc. | 1.79B | 0.75% | 571,542 | 5.79M |
| 93 | VRDN | Viridian Therapeutics, Inc. | 1.77B | 3.43% | 236,059 | 305.00K |
| 94 | GPCR | Structure Therapeutics Inc. | 1.74B | 0.25% | 285,279 | - |
| 95 | STOK | Stoke Therapeutics, Inc. | 1.72B | 4.01% | 289,076 | 199.89M |
| 96 | ABCL | AbCellera Biologics Inc. | 1.69B | 1.99% | 2,813,255 | 32.88M |
| 97 | VCEL | Vericel Corporation | 1.67B | 3.72% | 181,416 | 249.12M |
| 98 | IMCR | Immunocore Holdings plc | 1.66B | 1.67% | 169,388 | 356.15M |
| 99 | BHVN | Biohaven Ltd. | 1.64B | -2.09% | 640,474 | - |
| 100 | EWTX | Edgewise Therapeutics, Inc. | 1.58B | -0.46% | 95,867 | - |
| 101 | PHVS | Pharvaris N.V. | 1.58B | -0.32% | 47,967 | - |
| 102 | MNKD | MannKind Corporation | 1.57B | 5.12% | 2,410,633 | 301.74M |
| 103 | JANX | Janux Therapeutics, Inc. | 1.57B | -1.66% | 673,796 | 439.00K |
| 104 | HRMY | Harmony Biosciences Holdings, Inc. | 1.51B | -0.94% | 274,751 | 772.53M |
| 105 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | -1.47% | 842,977 | -249.00K |
| 106 | AUPH | Aurinia Pharmaceuticals Inc. | 1.48B | -0.53% | 467,109 | 260.11M |
| 107 | TSHA | Taysha Gene Therapies, Inc. | 1.39B | 4.71% | 1,908,232 | 8.10M |
| 108 | NVAX | Novavax, Inc. | 1.39B | 3.00% | 2,242,562 | 1.08B |
| 109 | ORIC | ORIC Pharmaceuticals, Inc. | 1.36B | 2.63% | 634,249 | - |
| 110 | ZYME | Zymeworks Inc. | 1.36B | 0.17% | 172,623 | 122.87M |
| 111 | SNDX | Syndax Pharmaceuticals, Inc. | 1.36B | -1.87% | 951,464 | 77.93M |
| 112 | DNTH | Dianthus Therapeutics, Inc. | 1.33B | 0.10% | 392,560 | 4.85M |
| 113 | XERS | Xeris Biopharma Holdings, Inc. | 1.30B | 0.75% | 830,323 | 246.03M |
| 114 | SION | Sionna Therapeutics, Inc. | 1.30B | 0.03% | 306,817 | - |
| 115 | NBTX | Nanobiotix S.A. | 1.26B | 22.67% | 132,626 | 11.93M |
| 116 | YDES | YD Bio Limited | 1.25B | 2.35% | 14,235 | 510.36K |
| 117 | MAZE | Maze Therapeutics, Inc. | 1.25B | 3.90% | 314,115 | 2.50M |
| 118 | IMTX | Immatics N.V. | 1.25B | -0.87% | 405,794 | 152.82M |
| 119 | NUVB | Nuvation Bio Inc. | 1.25B | -2.54% | 2,265,143 | 14.36M |
| 120 | IMNM | Immunome, Inc. | 1.25B | 2.87% | 489,080 | 12.59M |
| 121 | WVE | Wave Life Sciences Ltd. | 1.24B | 2.37% | 943,316 | 93.95M |
| 122 | TRML | Tourmaline Bio, Inc. | 1.24B | 0.04% | 121,423 | - |
| 123 | ORKA | Oruka Therapeutics, Inc. | 1.23B | 3.67% | 269,891 | - |
| 124 | RAPP | Rapport Therapeutics, Inc. | 1.23B | 0.53% | 221,518 | - |
| 125 | ELVN | Enliven Therapeutics, Inc. | 1.22B | -1.01% | 153,031 | - |
| 126 | ARDX | Ardelyx, Inc. | 1.22B | 2.23% | 2,795,579 | 386.15M |
| 127 | CVAC | CureVac N.V. | 1.21B | 0.19% | 230,635 | 599.54M |
| 128 | SYRE | Spyre Therapeutics, Inc. | 1.17B | 1.62% | 202,856 | - |
| 129 | TRVI | Trevi Therapeutics, Inc. | 1.16B | -4.60% | 373,575 | - |
| 130 | ATAI | Atai Life Sciences N.V. | 1.14B | 4.51% | 2,430,120 | 2.31M |
| 131 | SANA | Sana Biotechnology, Inc. | 1.14B | 0.46% | 1,102,227 | - |
| 132 | ZBIO | Zenas BioPharma, Inc. | 1.13B | 1.17% | 179,762 | 15.00M |
| 133 | LENZ | LENZ Therapeutics, Inc. | 1.13B | 2.06% | 787,798 | 5.00M |
| 134 | PRAX | Praxis Precision Medicines, Inc. | 1.12B | -0.21% | 100,042 | 7.77M |
| 135 | SEPN | Septerna, Inc. | 1.10B | 7.41% | 135,106 | 726.00K |
| 136 | SPRY | ARS Pharmaceuticals, Inc. | 1.10B | -1.41% | 666,376 | 112.34M |
| 137 | OCS | Oculis Holding AG | 1.10B | -0.33% | 65,425 | 960.67K |
| 138 | NKTR | Nektar Therapeutics | 1.08B | 4.25% | 125,632 | 74.93M |
| 139 | UPB | Upstream Bio, Inc. | 1.08B | 1.80% | 93,262 | 2.72M |
| 140 | INVA | Innoviva, Inc. | 1.07B | -1.73% | 249,713 | 370.23M |
| 141 | RLAY | Relay Therapeutics, Inc. | 1.07B | -4.31% | 721,612 | 8.36M |
| 142 | BCAX | Bicara Therapeutics Inc. | 997.22M | 2.70% | 712,607 | - |
| 143 | PHAR | Pharming Group N.V. | 987.54M | 2.14% | 23,359 | 339.84M |
| 144 | XNCR | Xencor, Inc. | 978.55M | 5.30% | 282,099 | 146.93M |
| 145 | MDXG | MiMedx Group, Inc. | 963.22M | -0.61% | 157,970 | 363.77M |
| 146 | MNMD | Mind Medicine (MindMed) Inc. | 945.77M | 5.25% | 958,644 | - |
| 147 | PRME | Prime Medicine, Inc. | 941.46M | -1.94% | 1,714,280 | 4.96M |
| 148 | PGEN | Precigen, Inc. | 938.61M | 0.96% | 3,362,920 | 4.34M |
| 149 | ANAB | AnaptysBio, Inc. | 925.16M | 5.34% | 240,918 | 123.16M |
| 150 | TNGX | Tango Therapeutics, Inc. | 919.01M | 15.69% | 1,209,506 | 24.30M |
| 151 | EYPT | EyePoint Pharmaceuticals, Inc. | 913.29M | -2.36% | 249,467 | 51.90M |
| 152 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 910.76M | -2.71% | 197,330 | - |
| 153 | FTRE | Fortrea Holdings Inc. | 897.10M | 2.12% | 362,469 | 2.73B |
| 154 | VALN | Valneva SE | 894.91M | 1.25% | 8,154 | 230.57M |
| 155 | KURA | Kura Oncology, Inc. | 877.95M | 2.69% | 683,175 | 83.28M |
| 156 | AVBP | ArriVent BioPharma, Inc. | 849.72M | 0.41% | 76,064 | - |
| 157 | PROK | ProKidney Corp. | 847.53M | -4.64% | 1,142,684 | 527.00K |
| 158 | MRVI | Maravai LifeSciences Holdings, Inc. | 845.25M | 3.76% | 959,271 | 219.83M |
| 159 | PHAT | Phathom Pharmaceuticals, Inc. | 831.60M | 1.02% | 373,436 | 114.04M |
| 160 | VIR | Vir Biotechnology, Inc. | 821.00M | 1.90% | 360,667 | 19.00M |
| 161 | CRMD | CorMedix Inc. | 814.15M | -2.80% | 1,149,590 | 121.48M |
| 162 | GERN | Geron Corporation | 810.28M | -3.05% | 7,176,691 | 164.45M |
| 163 | ABUS | Arbutus Biopharma Corporation | 809.93M | 2.80% | 253,124 | 15.42M |
| 164 | PVLA | Palvella Therapeutics, Inc. | 809.57M | 4.72% | 96,729 | - |
| 165 | GHRS | GH Research PLC | 801.73M | 2.66% | 46,236 | - |
| 166 | IOVA | Iovance Biotherapeutics, Inc. | 763.51M | 0.48% | 4,762,480 | 241.53M |
| 167 | GYRE | Gyre Therapeutics, Inc. | 760.22M | 5.15% | 50,018 | 102.19M |
| 168 | URGN | UroGen Pharma Ltd. | 759.89M | -1.53% | 540,139 | 94.24M |
| 169 | TYRA | Tyra Biosciences, Inc. | 750.03M | 4.09% | 66,676 | - |
| 170 | RZLT | Rezolute, Inc. | 748.29M | -0.36% | 749,064 | - |
| 171 | NRIX | Nurix Therapeutics, Inc. | 743.08M | -0.97% | 575,064 | 83.69M |
| 172 | DAWN | Day One Biopharmaceuticals, Inc. | 741.10M | -0.07% | 344,829 | 187.64M |
| 173 | DNA | Ginkgo Bioworks Holdings, Inc. | 739.93M | -1.26% | 799,700 | 230.82M |
| 174 | OLMA | Olema Pharmaceuticals, Inc. | 738.51M | 1.80% | 280,827 | - |
| 175 | CMPX | Compass Therapeutics, Inc. | 737.76M | 1.42% | 1,068,174 | 850.00K |
| 176 | AVXL | Anavex Life Sciences Corp. | 725.80M | -8.85% | 1,469,406 | - |
| 177 | TERN | Terns Pharmaceuticals, Inc. | 722.91M | 1.36% | 328,417 | - |
| 178 | SVRA | Savara Inc. | 718.45M | 1.19% | 270,772 | - |
| 179 | ARVN | Arvinas, Inc. | 705.54M | 1.59% | 3,645,673 | 372.80M |
| 180 | TBPH | Theravance Biopharma, Inc. | 703.04M | -0.21% | 155,946 | 77.21M |
| 181 | MNPR | Monopar Therapeutics Inc. | 693.42M | 9.60% | 57,089 | - |
| 182 | IMAB | I-Mab | 683.53M | 24.32% | 3,845,912 | 569.46K |
| 183 | ERAS | Erasca, Inc. | 680.81M | -0.41% | 641,872 | - |
| 184 | MLTX | MoonLake Immunotherapeutics | 670.57M | 2.92% | 3,252,772 | - |
| 185 | MBX | MBX Biosciences, Inc. | 661.34M | -0.80% | 208,058 | - |
| 186 | KROS | Keros Therapeutics, Inc. | 651.47M | 2.17% | 246,737 | 232.84M |
| 187 | IVA | Inventiva S.A. | 644.56M | -0.66% | 110,939 | 19.93M |
| 188 | KOD | Kodiak Sciences Inc. | 620.32M | -0.84% | 248,975 | - |
| 189 | GLUE | Monte Rosa Therapeutics, Inc. | 616.36M | -0.60% | 912,198 | 177.99M |
| 190 | MGTX | MeiraGTx Holdings plc | 609.79M | -3.32% | 148,213 | 37.92M |
| 191 | NAGE | Niagen Bioscience, Inc. | 598.60M | 0.13% | 418,689 | 116.30M |
| 192 | ZVRA | Zevra Therapeutics, Inc. | 596.72M | -3.45% | 921,806 | 62.02M |
| 193 | RGNX | REGENXBIO Inc. | 582.93M | 5.68% | 243,316 | 155.78M |
| 194 | KALV | KalVista Pharmaceuticals, Inc. | 581.02M | - | 366,932 | 1.43M |
| 195 | BCYC | Bicycle Therapeutics plc | 573.16M | -0.60% | 74,217 | 19.28M |
| 196 | VSTM | Verastem, Inc. | 560.68M | 6.30% | 575,426 | 2.14M |
| 197 | CTMX | CytomX Therapeutics, Inc. | 554.11M | - | 1,030,367 | 141.10M |
| 198 | GOSS | Gossamer Bio, Inc. | 554.01M | 5.70% | 1,732,698 | 40.24M |
| 199 | PRTA | Prothena Corporation plc | 545.84M | 0.90% | 294,864 | 10.34M |
| 200 | ABSI | Absci Corporation | 539.78M | -1.90% | 4,702,200 | 4.14M |
| 201 | CRVS | Corvus Pharmaceuticals, Inc. | 535.76M | 3.75% | 674,388 | - |
| 202 | ARCT | Arcturus Therapeutics Holdings Inc. | 531.14M | 3.22% | 295,537 | 122.12M |
| 203 | LXRX | Lexicon Pharmaceuticals, Inc. | 516.03M | -4.70% | 1,976,708 | 58.43M |
| 204 | INBX | Inhibrx Biosciences, Inc. | 492.50M | 4.73% | 70,389 | 1.40M |
| 205 | ADCT | ADC Therapeutics SA | 491.62M | -1.13% | 499,656 | 77.25M |
| 206 | RIGL | Rigel Pharmaceuticals, Inc. | 486.10M | -3.83% | 393,166 | 267.92M |
| 207 | OCGN | Ocugen, Inc. | 485.63M | -9.06% | 7,898,288 | 4.75M |
| 208 | ALMS | Alumis Inc. | 484.94M | 4.95% | 221,590 | 20.06M |
| 209 | FULC | Fulcrum Therapeutics, Inc. | 482.50M | -0.78% | 92,197 | 80.00M |
| 210 | ATXS | Astria Therapeutics, Inc. | 478.57M | 2.05% | 110,397 | - |
| 211 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 212 | SLDB | Solid Biosciences Inc. | 466.44M | 0.50% | 394,695 | - |
| 213 | CGEM | Cullinan Therapeutics, Inc. | 463.14M | 5.95% | 1,151,332 | - |
| 214 | LXEO | Lexeo Therapeutics, Inc. | 455.20M | 2.31% | 718,651 | - |
| 215 | AUTL | Autolus Therapeutics plc | 445.79M | 0.90% | 1,697,791 | 29.93M |
| 216 | DRUG | Bright Minds Biosciences Inc. | 440.57M | -4.06% | 53,542 | - |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 439.00M | 5.62% | 1,514,143 | 33.00K |
| 218 | XOMA | XOMA Royalty Corporation | 438.91M | -0.33% | 11,473 | 44.95M |
| 219 | RAPT | RAPT Therapeutics, Inc. | 437.92M | -1.16% | 190,988 | - |
| 220 | NGNE | Neurogene Inc. | 437.58M | 1.49% | 95,337 | 925.00K |
| 221 | KRRO | Korro Bio, Inc. | 427.94M | 6.05% | 120,553 | 6.28M |
| 222 | PRTC | PureTech Health plc | 421.59M | -1.40% | 839 | 6.39M |
| 223 | ENGN | enGene Holdings Inc. | 419.26M | -2.38% | 73,329 | - |
| 224 | ASMB | Assembly Biosciences, Inc. | 413.90M | 0.34% | 128,921 | 33.25M |
| 225 | DBVT | DBV Technologies S.A. | 411.74M | -0.40% | 29,143 | 3.80M |
| 226 | LCTX | Lineage Cell Therapeutics, Inc. | 392.77M | 3.61% | 1,562,874 | 10.91M |
| 227 | BNTC | Benitec Biopharma Inc. | 391.66M | - | 17,817 | - |
| 228 | IMRX | Immuneering Corporation | 387.02M | -0.16% | 1,226,230 | - |
| 229 | AURA | Aura Biosciences, Inc. | 381.42M | 3.72% | 194,906 | - |
| 230 | RCKT | Rocket Pharmaceuticals, Inc. | 374.97M | 1.61% | 1,127,100 | - |
| 231 | DSGN | Design Therapeutics, Inc. | 371.87M | -3.26% | 118,727 | - |
| 232 | LBRX | LB Pharmaceuticals Inc | 360.10M | 3.92% | 69,755 | - |
| 233 | DMAC | DiaMedica Therapeutics Inc. | 358.20M | 4.37% | 92,221 | - |
| 234 | REPL | Replimune Group, Inc. | 355.93M | 0.66% | 688,000 | - |
| 235 | LRMR | Larimar Therapeutics, Inc. | 355.20M | -4.82% | 877,137 | - |
| 236 | CADL | Candel Therapeutics, Inc. | 354.07M | 4.20% | 359,684 | - |
| 237 | ACIU | AC Immune SA | 350.26M | -0.28% | 214,654 | 36.36M |
| 238 | TNYA | Tenaya Therapeutics, Inc. | 347.95M | 1.67% | 3,950,849 | - |
| 239 | ALT | Altimmune, Inc. | 347.73M | 0.51% | 1,367,020 | 20.00K |
| 240 | IVVD | Invivyd, Inc. | 341.17M | -0.57% | 2,746,124 | 46.21M |
| 241 | ANNX | Annexon, Inc. | 334.60M | -1.77% | 605,502 | - |
| 242 | CTNM | Contineum Therapeutics, Inc. | 332.59M | -0.16% | 24,198 | - |
| 243 | DRTS | Alpha Tau Medical Ltd. | 330.82M | 2.91% | 16,994 | - |
| 244 | EDIT | Editas Medicine, Inc. | 326.86M | -2.28% | 1,152,201 | 38.90M |
| 245 | LYEL | Lyell Immunopharma, Inc. | 326.78M | 3.03% | 9,997 | 60.00K |
| 246 | CLLS | Cellectis S.A. | 326.35M | 12.62% | 85,255 | 63.44M |
| 247 | AARD | Aardvark Therapeutics, Inc. | 322.20M | -8.67% | 66,920 | - |
| 248 | GALT | Galectin Therapeutics Inc. | 321.58M | 6.36% | 246,265 | - |
| 249 | ETHZ | ETHZilla Corporation | 318.75M | 0.51% | 8,300,809 | - |
| 250 | MREO | Mereo BioPharma Group plc | 316.60M | 1.53% | 629,101 | 500.00K |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 314.46M | 2.36% | 226,204 | 64.81M |
| 252 | VNDA | Vanda Pharmaceuticals Inc. | 312.58M | -0.38% | 281,587 | 203.47M |
| 253 | ALDX | Aldeyra Therapeutics, Inc. | 312.54M | -3.43% | 409,034 | - |
| 254 | PEPG | PepGen Inc. | 309.32M | -4.56% | 311,117 | - |
| 255 | CAPR | Capricor Therapeutics, Inc. | 307.22M | -5.22% | 659,031 | 13.39M |
| 256 | EPRX | Eupraxia Pharmaceuticals Inc. | 303.63M | 0.91% | 8,759 | - |
| 257 | NMRA | Neumora Therapeutics, Inc. | 299.60M | -2.12% | 202,188 | - |
| 258 | ALEC | Alector, Inc. | 298.58M | -2.32% | 643,720 | 81.13M |
| 259 | TECX | Tectonic Therapeutic, Inc. | 298.27M | -0.50% | 134,653 | - |
| 260 | KYTX | Kyverna Therapeutics, Inc. | 296.23M | 3.32% | 191,663 | - |
| 261 | TENX | Tenax Therapeutics, Inc. | 294.33M | -1.34% | 14,514 | - |
| 262 | JBIO | Jade Biosciences, Inc. | 292.82M | -1.16% | 79,409 | - |
| 263 | ALLO | Allogene Therapeutics, Inc. | 281.57M | 3.17% | 2,879,900 | 22.00K |
| 264 | ABEO | Abeona Therapeutics Inc. | 281.26M | 2.33% | 633,659 | 400.00K |
| 265 | OMER | Omeros Corporation | 279.71M | -1.91% | 384,918 | - |
| 266 | IMMP | Immutep Limited | 278.39M | 0.50% | 136,460 | 3.31M |
| 267 | VYGR | Voyager Therapeutics, Inc. | 273.46M | -1.40% | 398,534 | 42.58M |
| 268 | VTYX | Ventyx Biosciences, Inc. | 264.55M | 4.21% | 532,627 | - |
| 269 | HUMA | Humacyte, Inc. | 264.46M | 6.73% | 4,852,092 | 818.00K |
| 270 | FBRX | Forte Biosciences, Inc. | 262.50M | -3.60% | 38,541 | - |
| 271 | PBYI | Puma Biotechnology, Inc. | 261.42M | 1.37% | 264,213 | 238.06M |
| 272 | SLN | Silence Therapeutics plc | 259.31M | 9.80% | 110,131 | 27.17M |
| 273 | SGMT | Sagimet Biosciences Inc. | 253.02M | 1.37% | 280,051 | - |
| 274 | PRQR | ProQR Therapeutics N.V. | 249.14M | -1.87% | 203,425 | 20.13M |
| 275 | RNAC | Cartesian Therapeutics, Inc. | 248.06M | 2.36% | 22,449 | 1.03M |
| 276 | AVIR | Atea Pharmaceuticals, Inc. | 244.42M | -1.91% | 148,368 | - |
| 277 | TLSA | Tiziana Life Sciences Ltd | 241.75M | -0.27% | 249,021 | - |
| 278 | FHTX | Foghorn Therapeutics Inc. | 241.10M | 5.05% | 115,703 | 24.17M |
| 279 | HRTX | Heron Therapeutics, Inc. | 239.23M | 1.95% | 365,467 | 149.69M |
| 280 | ZURA | Zura Bio Limited | 238.62M | -11.57% | 1,092,915 | - |
| 281 | FENC | Fennec Pharmaceuticals Inc. | 237.13M | -0.58% | 33,249 | 33.30M |
| 282 | CABA | Cabaletta Bio, Inc. | 235.07M | 10.78% | 3,551,053 | - |
| 283 | OABI | OmniAb, Inc. | 231.77M | -0.31% | 214,078 | 23.03M |
| 284 | CRBU | Caribou Biosciences, Inc. | 227.69M | -1.81% | 437,683 | 9.12M |
| 285 | CDXS | Codexis, Inc. | 227.47M | -2.70% | 522,272 | 57.16M |
| 286 | MDWD | MediWound Ltd. | 227.32M | -2.42% | 67,759 | 19.86M |
| 287 | VOR | Vor Biopharma Inc. | 225.56M | 5.38% | 158,997 | - |
| 288 | BDTX | Black Diamond Therapeutics, Inc. | 222.05M | -4.65% | 1,134,397 | 70.00M |
| 289 | GNFT | Genfit S.A. | 216.82M | -1.51% | 342 | 52.99M |
| 290 | CBIO | Crescent Biopharma, Inc. | 216.61M | -2.38% | 64,934 | - |
| 291 | NTHI | NeOnc Technologies Holdings, Inc. | 211.71M | -5.31% | 31,233 | 59.99K |
| 292 | TRDA | Entrada Therapeutics, Inc. | 210.47M | -2.79% | 46,169 | 79.48M |
| 293 | SLS | SELLAS Life Sciences Group, Inc. | 209.54M | 4.19% | 4,547,574 | - |
| 294 | ACRS | Aclaris Therapeutics, Inc. | 209.08M | 3.21% | 311,001 | 16.79M |
| 295 | PYXS | Pyxis Oncology, Inc. | 208.38M | -9.19% | 874,876 | 2.82M |
| 296 | TARA | Protara Therapeutics, Inc. | 204.48M | 1.53% | 357,296 | - |
| 297 | SGMO | Sangamo Therapeutics, Inc. | 204.41M | 0.77% | 3,866,019 | 81.71M |
| 298 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 201.84M | 5.98% | 246,709 | - |
| 299 | GNLX | Genelux Corporation | 200.14M | 5.72% | 131,317 | 8.00K |
| 300 | CHRS | Coherus Oncology, Inc. | 199.33M | 2.69% | 525,997 | 272.21M |
| 301 | SAVA | Cassava Sciences, Inc. | 196.61M | 8.82% | 1,476,280 | - |
| 302 | CGEN | Compugen Ltd. | 196.42M | 13.51% | 625,688 | 22.14M |
| 303 | MIST | Milestone Pharmaceuticals Inc. | 194.83M | - | 1,297,338 | - |
| 304 | PLX | Protalix BioTherapeutics, Inc. | 189.76M | 0.85% | 368,476 | 61.95M |
| 305 | TTRX | Turn Therapeutics Inc. | 187.47M | -10.20% | 366,161 | - |
| 306 | ACTU | Actuate Therapeutics, Inc. | 186.58M | 4.49% | 31,000 | - |
| 307 | IPHA | Innate Pharma S.A. | 182.34M | -0.99% | 2,007 | 14.84M |
| 308 | PALI | Palisade Bio, Inc. | 178.31M | -7.75% | 5,103,578 | - |
| 309 | AVTX | Avalo Therapeutics, Inc. | 178.28M | -2.83% | 192,463 | 441.00K |
| 310 | TNXP | Tonix Pharmaceuticals Holding Corp. | 178.12M | -4.11% | 498,139 | 9.83M |
| 311 | GUTS | Fractyl Health, Inc. | 175.82M | -0.75% | 968,983 | 17.00K |
| 312 | ELTX | Elicio Therapeutics, Inc. | 174.83M | 1.23% | 49,963 | - |
| 313 | MCRB | Seres Therapeutics, Inc. | 168.18M | 0.47% | 57,516 | - |
| 314 | FATE | Fate Therapeutics, Inc. | 167.80M | -11.01% | 1,419,148 | 8.47M |
| 315 | OBIO | Orchestra BioMed Holdings, Inc. | 166.72M | -1.90% | 141,885 | 2.94M |
| 316 | ELDN | Eledon Pharmaceuticals, Inc. | 162.58M | -0.91% | 334,014 | - |
| 317 | ACHV | Achieve Life Sciences, Inc. | 159.96M | 1.62% | 343,301 | - |
| 318 | NKTX | Nkarta, Inc. | 158.38M | 3.24% | 554,777 | - |
| 319 | ANRO | Alto Neuroscience, Inc. | 157.04M | 2.84% | 126,123 | - |
| 320 | NVCT | Nuvectis Pharma, Inc. | 156.05M | 2.85% | 26,890 | - |
| 321 | CGTX | Cognition Therapeutics, Inc. | 153.51M | -4.92% | 1,127,638 | - |
| 322 | VTVT | vTv Therapeutics Inc. | 153.19M | -2.21% | 952 | 17.00K |
| 323 | CCCC | C4 Therapeutics, Inc. | 150.17M | -6.22% | 1,437,837 | 34.24M |
| 324 | CYBN | Cybin Inc. | 149.93M | -1.16% | 230,121 | - |
| 325 | CRDF | Cardiff Oncology, Inc. | 149.68M | 1.81% | 220,662 | 545.00K |
| 326 | ANIX | Anixa Biosciences, Inc. | 146.81M | 3.00% | 221,069 | - |
| 327 | GLSI | Greenwich LifeSciences, Inc. | 142.37M | -1.93% | 38,276 | - |
| 328 | TVGN | Tevogen Bio Holdings Inc. | 140.57M | -0.07% | 217,940 | - |
| 329 | ATOS | Atossa Therapeutics, Inc. | 140.15M | 0.46% | 1,056,578 | - |
| 330 | APLT | Applied Therapeutics, Inc. | 139.76M | 3.21% | 1,951,239 | 121.00K |
| 331 | MOLN | Molecular Partners AG | 139.45M | -0.26% | 2,931 | 856.30K |
| 332 | TIL | Instil Bio, Inc. | 138.86M | 6.97% | 96,359 | - |
| 333 | CLYM | Climb Bio, Inc. | 132.14M | 8.33% | 347,648 | - |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 130.84M | 0.93% | 317,379 | - |
| 335 | INO | Inovio Pharmaceuticals, Inc. | 130.20M | -4.67% | 581,534 | 182.34K |
| 336 | CNTX | Context Therapeutics Inc. | 128.28M | 2.14% | 322,264 | - |
| 337 | SEER | Seer, Inc. | 128.10M | -1.36% | 54,395 | 16.29M |
| 338 | AGEN | Agenus Inc. | 127.46M | 0.76% | 213,268 | 101.71M |
| 339 | SPRO | Spero Therapeutics, Inc. | 126.62M | - | 440,612 | 48.58M |
| 340 | IRD | Opus Genetics, Inc. | 124.83M | 1.02% | 527,579 | 15.42M |
| 341 | HURA | TuHURA Biosciences, Inc. | 123.12M | 2.93% | 96,848 | - |
| 342 | ENTX | Entera Bio Ltd. | 121.92M | 0.75% | 216,168 | 166.00K |
| 343 | TCRX | TScan Therapeutics, Inc. | 121.44M | -3.17% | 379,347 | 6.96M |
| 344 | IKT | Inhibikase Therapeutics, Inc. | 120.34M | 0.31% | 23,347 | 1.00 |
| 345 | SRZN | Surrozen, Inc. | 119.98M | 1.70% | 22,887 | 12.62M |
| 346 | STTK | Shattuck Labs, Inc. | 119.04M | 2.45% | 348,227 | 3.00M |
| 347 | VTGN | Vistagen Therapeutics, Inc. | 118.73M | -3.97% | 203,109 | 646.00K |
| 348 | ZNTL | Zentalis Pharmaceuticals, Inc. | 118.66M | -2.08% | 253,816 | 26.87M |
| 349 | ONCY | Oncolytics Biotech Inc. | 117.42M | -2.50% | 823,025 | - |
| 350 | OVID | Ovid Therapeutics Inc. | 117.33M | -1.20% | 1,069,753 | 6.65M |
| 351 | ARMP | Armata Pharmaceuticals, Inc. | 116.67M | 1.59% | 4,377 | 6.87M |
| 352 | BMEA | Biomea Fusion, Inc. | 115.95M | -2.38% | 1,308,740 | - |
| 353 | ACOG | Alpha Cognition Inc. | 115.06M | 1.42% | 48,548 | 4.59M |
| 354 | NAUT | Nautilus Biotechnology, Inc. | 113.62M | 5.76% | 172,235 | - |
| 355 | MGX | Metagenomi, Inc. | 112.22M | 4.55% | 451,031 | 33.77M |
| 356 | EXOZ | eXoZymes, Inc. | 107.44M | -1.08% | 300 | -700.00 |
| 357 | ATRA | Atara Biotherapeutics, Inc. | 106.41M | 5.76% | 30,809 | 188.67M |
| 358 | MGNX | MacroGenics, Inc. | 105.55M | -1.18% | 263,858 | 165.50M |
| 359 | QNCX | Quince Therapeutics, Inc. | 105.01M | 4.55% | 221,358 | - |
| 360 | SLGL | Sol-Gel Technologies Ltd. | 104.75M | -3.57% | 8,436 | 23.93M |
| 361 | CNTB | Connect Biopharma Holdings Limited | 103.64M | - | 55,718 | 1.97M |
| 362 | COYA | Coya Therapeutics, Inc. | 101.69M | 0.16% | 20,131 | 423.45K |
| 363 | ORMP | Oramed Pharmaceuticals Inc. | 97.34M | -1.49% | 18,787 | 2.00M |
| 364 | SPRB | Spruce Biosciences, Inc. | 96.64M | -1.21% | 80,891 | 1.30M |
| 365 | ALXO | ALX Oncology Holdings Inc. | 96.39M | 9.76% | 476,617 | - |
| 366 | PRLD | Prelude Therapeutics Incorporated | 96.31M | 0.40% | 56,883 | 7.00M |
| 367 | ANEB | Anebulo Pharmaceuticals, Inc. | 95.32M | - | 16,630 | - |
| 368 | ATYR | aTyr Pharma, Inc. | 95.24M | -8.30% | 6,101,963 | 235.00K |
| 369 | WHWK | Whitehawk Therapeutics, Inc. | 95.20M | - | 7,327 | 21.60M |
| 370 | ADVM | Adverum Biotechnologies, Inc. | 95.00M | -5.88% | 94,032 | 1.00M |
| 371 | NTRB | Nutriband Inc. | 92.28M | 2.26% | 7,364 | 2.58M |
| 372 | ACET | Adicet Bio, Inc. | 90.62M | 2.17% | 2,074,663 | - |
| 373 | ADAG | Adagene Inc. | 90.49M | -1.54% | 22,376 | 103.20K |
| 374 | CSBR | Champions Oncology, Inc. | 90.18M | - | 3,991 | 56.88M |
| 375 | PLRX | Pliant Therapeutics, Inc. | 89.63M | -0.68% | 72,953 | - |
| 376 | IMUX | Immunic, Inc. | 88.79M | 0.17% | 708,057 | - |
| 377 | KLRS | Kalaris Therapeutics, Inc. | 88.46M | 6.29% | 176,470 | - |
| 378 | IFRX | InflaRx N.V. | 87.73M | -6.16% | 495,955 | 191.22K |
| 379 | HYFT | MindWalk Holdings Corp. | 87.24M | 4.42% | 295,618 | 18.21M |
| 380 | IMA | ImageneBio, Inc. | 86.66M | -2.64% | 16,368 | 4.30M |
| 381 | VXRT | Vaxart, Inc. | 84.45M | 6.38% | 515,805 | 80.72M |
| 382 | FBIO | Fortress Biotech, Inc. | 83.02M | 2.95% | 211,065 | 59.30M |
| 383 | IMMX | Immix Biopharma, Inc. | 80.85M | -1.00% | 455,856 | - |
| 384 | VANI | Vivani Medical, Inc. | 80.57M | -0.73% | 72,855 | - |
| 385 | CBUS | Cibus, Inc. | 79.73M | 5.00% | 60,263 | 4.85M |
| 386 | XBIT | XBiotech Inc. | 79.12M | 2.17% | 60,136 | - |
| 387 | RPTX | Repare Therapeutics Inc. | 78.83M | 1.94% | 57,061 | 250.00K |
| 388 | CVM | CEL-SCI Corporation | 78.77M | 2.55% | 30,273 | - |
| 389 | UNCY | Unicycive Therapeutics, Inc. | 78.59M | 0.23% | 176,513 | - |
| 390 | ATHE | Alterity Therapeutics Limited | 77.80M | 7.69% | 72,822 | 3.57M |
| 391 | LITS | Lite Strategy, Inc. | 77.73M | -11.74% | 818,469 | - |
| 392 | OKYO | OKYO Pharma Limited | 76.73M | 4.40% | 44,526 | - |
| 393 | EQ | Equillium, Inc. | 76.16M | -4.48% | 517,602 | 16.55M |
| 394 | HOWL | Werewolf Therapeutics, Inc. | 75.00M | 0.61% | 614,346 | 1.14M |
| 395 | NRXP | NRx Pharmaceuticals, Inc. | 74.64M | -0.95% | 229,920 | - |
| 396 | COEP | Coeptis Therapeutics Holdings, Inc. | 74.28M | -1.85% | 29,110 | 263.56K |
| 397 | CRVO | CervoMed Inc. | 73.84M | -2.09% | 54,584 | 7.78M |
| 398 | PMVP | PMV Pharmaceuticals, Inc. | 71.54M | - | 335,258 | - |
| 399 | XFOR | X4 Pharmaceuticals, Inc. | 70.72M | 1.94% | 99,033 | 32.77M |
| 400 | GANX | Gain Therapeutics, Inc. | 70.64M | -0.25% | 383,799 | - |
| 401 | CAMP | Camp4 Therapeutics Corporation | 69.86M | -6.60% | 84,099 | 3.01M |
| 402 | PTHS | Pelthos Therapeutics Inc. | 69.59M | -1.66% | 5 | - |
| 403 | STRO | Sutro Biopharma, Inc. | 69.49M | 1.99% | 362,260 | 104.47M |
| 404 | BYSI | BeyondSpring Inc. | 69.37M | -1.15% | 13,175 | 1.88M |
| 405 | NSRX | Nasus Pharma Ltd. | 69.22M | -0.78% | 4,902 | - |
| 406 | ABVC | ABVC BioPharma, Inc. | 67.98M | -1.97% | 32,209 | 391.24K |
| 407 | ARTV | Artiva Biotherapeutics, Inc. | 67.17M | -2.14% | 13,452 | 251.00K |
| 408 | PSTV | Plus Therapeutics, Inc. | 66.51M | -3.92% | 6,170,211 | 5.32M |
| 409 | JSPR | Jasper Therapeutics, Inc. | 66.46M | -0.83% | 137,481 | - |
| 410 | DTIL | Precision BioSciences, Inc. | 66.01M | -0.36% | 34,959 | 1.26M |
| 411 | RLMD | Relmada Therapeutics, Inc. | 65.72M | -2.94% | 83,795 | - |
| 412 | GNTA | Genenta Science S.p.A. | 64.52M | 3.69% | 51,452 | - |
| 413 | CUE | Cue Biopharma, Inc. | 64.15M | 4.93% | 97,514 | 8.29M |
| 414 | TVRD | Tvardi Therapeutics, Inc. | 63.77M | -83.65% | 5,229,265 | - |
| 415 | INKT | MiNK Therapeutics, Inc. | 63.34M | 0.04% | 13,889 | - |
| 416 | OSTX | OS Therapies Incorporated | 62.34M | -1.01% | 175,691 | - |
| 417 | ICCC | ImmuCell Corporation | 61.96M | 0.74% | 17,671 | 28.27M |
| 418 | MNOV | MediciNova, Inc. | 61.31M | -0.79% | 6,534 | 134.60K |
| 419 | VERU | Veru Inc. | 59.99M | 4.20% | 149,969 | 16.89M |
| 420 | OTLK | Outlook Therapeutics, Inc. | 59.97M | 12.50% | 2,036,500 | 1.51M |
| 421 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 59.73M | -4.60% | 10,823,967 | - |
| 422 | ALGS | Aligos Therapeutics, Inc. | 59.55M | 2.65% | 163,100 | 3.17M |
| 423 | ANL | Adlai Nortye Ltd. | 58.96M | 1.76% | 900 | 1.94M |
| 424 | ACRV | Acrivon Therapeutics, Inc. | 56.31M | -2.19% | 411,292 | - |
| 425 | QNTM | Quantum BioPharma Ltd. | 55.63M | 5.38% | 53,253 | - |
| 426 | RADX | Radiopharm Theranostics Limited | 55.37M | 4.55% | 6,513 | 8.20M |
| 427 | BRNS | Barinthus Biotherapeutics plc | 55.12M | -0.74% | 13,992 | 14.97M |
| 428 | SER | Serina Therapeutics, Inc. | 54.70M | -2.24% | 20,408 | 130.00K |
| 429 | BCAB | BioAtla, Inc. | 54.53M | 7.04% | 586,524 | 11.00M |
| 430 | CELU | Celularity Inc. | 54.45M | -0.49% | 59,191 | 44.59M |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 54.13M | -3.03% | 743,747 | - |
| 432 | ESLA | Estrella Immunopharma, Inc. | 53.37M | 11.63% | 213,518 | - |
| 433 | MAIA | MAIA Biotechnology, Inc. | 52.13M | 3.95% | 321,183 | - |
| 434 | PYPD | PolyPid Ltd. | 51.82M | 5.08% | 60,811 | - |
| 435 | JUNS | Jupiter Neurosciences, Inc. | 51.20M | -3.92% | 47,819 | - |
| 436 | HYPD | Hyperion DeFi, Inc. | 50.94M | -8.84% | 677,673 | 44.44K |
| 437 | ADAP | Adaptimmune Therapeutics plc | 50.89M | 3.84% | 27,035,572 | 65.09M |
| 438 | KPTI | Karyopharm Therapeutics Inc. | 50.64M | 6.18% | 113,144 | 137.27M |
| 439 | TPST | Tempest Therapeutics, Inc. | 49.95M | 9.54% | 36,432 | - |
| 440 | BTAI | BioXcel Therapeutics, Inc. | 49.61M | -0.59% | 642,932 | 868.00K |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 49.29M | 6.03% | 267,759 | 81.00K |
| 442 | INMB | INmune Bio, Inc. | 48.92M | -1.08% | 283,690 | 50.00K |
| 443 | MRSN | Mersana Therapeutics, Inc. | 48.86M | 5.95% | 109,359 | 34.77M |
| 444 | SKYE | Skye Bioscience, Inc. | 48.65M | -9.25% | 1,028,478 | - |
| 445 | IPSC | Century Therapeutics, Inc. | 47.94M | -2.43% | 670,483 | 114.13M |
| 446 | LTRN | Lantern Pharma Inc. | 47.52M | 1.38% | 68,352 | - |
| 447 | QTTB | Q32 Bio Inc. | 46.78M | 7.42% | 431,884 | - |
| 448 | CALC | CalciMedica, Inc. | 45.13M | 2.05% | 23,610 | - |
| 449 | SNTI | Senti Biosciences, Inc. | 45.00M | 1.78% | 50,095 | - |
| 450 | PDSB | PDS Biotechnology Corporation | 44.97M | 0.95% | 190,745 | - |
| 451 | FGEN | FibroGen, Inc. | 43.14M | 1.12% | 7,283 | 7.35M |
| 452 | GBIO | Generation Bio Co. | 42.27M | 2.70% | 14,287 | 21.23M |
| 453 | GRCE | Grace Therapeutics, Inc. | 41.42M | 0.17% | 39,963 | - |
| 454 | NEUP | Neuphoria Therapeutics Inc. | 41.31M | 0.13% | 30,901 | 15.65M |
| 455 | OKUR | OnKure Therapeutics, Inc. | 41.27M | - | 39,810 | - |
| 456 | XLO | Xilio Therapeutics, Inc. | 40.69M | -1.13% | 86,659 | 15.00M |
| 457 | KLTO | Klotho Neurosciences, Inc. | 40.67M | -1.09% | 553,889 | - |
| 458 | LVTX | LAVA Therapeutics N.V. | 40.48M | -0.72% | 85,588 | 4.99M |
| 459 | RNXT | RenovoRx, Inc. | 39.94M | -1.80% | 341,265 | 662.00K |
| 460 | EVAX | Evaxion A/S | 39.79M | 6.78% | 304,105 | 3.18M |
| 461 | APLM | Apollomics, Inc. | 39.56M | - | - | 198.00K |
| 462 | DYAI | Dyadic International, Inc. | 38.72M | 1.90% | 66,799 | 4.14M |
| 463 | VRCA | Verrica Pharmaceuticals Inc. | 38.63M | -1.21% | 43,314 | 14.70M |
| 464 | IOBT | IO Biotech, Inc. | 38.42M | 5.63% | 968,617 | - |
| 465 | LIMN | Liminatus Pharma, Inc. | 37.89M | -0.71% | 169,461 | - |
| 466 | MURA | Mural Oncology plc | 36.04M | 0.48% | 31,092 | - |
| 467 | IGC | IGC Pharma, Inc. | 35.68M | -2.78% | 678,492 | 1.33M |
| 468 | PLUR | Pluri Inc. | 35.32M | -1.26% | 2,824 | 1.34M |
| 469 | ANTX | AN2 Therapeutics, Inc. | 34.37M | -0.19% | 56,605 | - |
| 470 | XCUR | Exicure, Inc. | 33.61M | 7.47% | 76,303 | 500.00K |
| 471 | RANI | Rani Therapeutics Holdings, Inc. | 33.51M | 1.75% | 399,397 | 1.20M |
| 472 | ITRM | Iterum Therapeutics plc | 33.27M | 0.43% | 341,053 | - |
| 473 | ANVS | Annovis Bio, Inc. | 32.15M | -2.94% | 725,573 | - |
| 474 | KZR | Kezar Life Sciences, Inc. | 30.83M | -0.24% | 16,291 | - |
| 475 | AKTX | Akari Therapeutics, Plc | 30.43M | 0.33% | 28,926 | - |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 29.80M | - | 57,406 | - |
| 477 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 29.73M | -1.25% | 210,133 | 1.00M |
| 478 | RNTX | Rein Therapeutics Inc. | 29.60M | -2.31% | 22,196 | - |
| 479 | CASI | CASI Pharmaceuticals, Inc. | 29.59M | -3.53% | 27,555 | 31.56M |
| 480 | NRXS | NeurAxis, Inc. | 29.57M | 0.50% | 3,464 | 3.22M |
| 481 | CVKD | Cadrenal Therapeutics, Inc. | 29.07M | 4.26% | 40,428 | - |
| 482 | BOLD | Boundless Bio, Inc. | 27.98M | -1.57% | 38,999 | - |
| 483 | DARE | Daré Bioscience, Inc. | 27.68M | -0.94% | 114,541 | -17.70K |
| 484 | CLGN | CollPlant Biotechnologies Ltd. | 27.53M | -1.59% | 9,380 | 2.40M |
| 485 | PASG | Passage Bio, Inc. | 27.09M | 0.62% | 3,910 | - |
| 486 | LNAI | Lunai Bioworks Inc. | 26.66M | 1.77% | 74,520 | - |
| 487 | ENLV | Enlivex Therapeutics Ltd. | 26.16M | -4.64% | 218,807 | - |
| 488 | LPTX | Leap Therapeutics, Inc. | 26.16M | -1.14% | 456,364 | - |
| 489 | KAPA | Kairos Pharma, Ltd. | 26.13M | 8.58% | 131,930 | - |
| 490 | PMN | ProMIS Neurosciences, Inc. | 25.29M | -4.08% | 561,063 | - |
| 491 | NNVC | NanoViricides, Inc. | 23.71M | -0.73% | 21,263 | - |
| 492 | SABS | SAB Biotherapeutics, Inc. | 23.63M | -0.87% | 72,540 | 114.70K |
| 493 | MTVA | MetaVia Inc. | 23.47M | -0.80% | 42,383 | - |
| 494 | MBRX | Moleculin Biotech, Inc. | 23.35M | -0.46% | 833,375 | - |
| 495 | PPCB | Propanc Biopharma, Inc. | 22.80M | 2.89% | 29,605 | - |
| 496 | ALLR | Allarity Therapeutics, Inc. | 22.66M | -3.11% | 206,848 | - |
| 497 | CING | Cingulate Inc. | 22.42M | -2.68% | 46,846 | - |
| 498 | GDTC | CytoMed Therapeutics Limited | 22.27M | -6.31% | 12,819 | 573.19K |
| 499 | CTXR | Citius Pharmaceuticals, Inc. | 21.69M | 3.66% | 262,288 | - |
| 500 | RLYB | Rallybio Corporation | 21.65M | 1.39% | 114,986 | 761.00K |
| 501 | BCTX | BriaCell Therapeutics Corp. | 21.54M | -6.44% | 78,989 | - |
| 502 | LIXT | Lixte Biotechnology Holdings, Inc. | 21.01M | -3.46% | 209,466 | - |
| 503 | PCSA | Processa Pharmaceuticals, Inc. | 20.87M | 9.42% | 5,003,673 | - |
| 504 | TRAW | Traws Pharma, Inc. | 20.59M | -3.16% | 191,206 | 2.90M |
| 505 | LSTA | Lisata Therapeutics, Inc. | 20.48M | -1.31% | 30,749 | 1.07M |
| 506 | CLSD | Clearside Biomedical, Inc. | 20.47M | -1.76% | 18,547 | 4.17M |
| 507 | HOTH | Hoth Therapeutics, Inc. | 20.02M | -4.43% | 457,837 | - |
| 508 | LEXX | Lexaria Bioscience Corp. | 19.99M | 4.94% | 172,099 | 615.92K |
| 509 | SYBX | Synlogic, Inc. | 19.54M | -0.60% | 2,584 | 8.00K |
| 510 | CRIS | Curis, Inc. | 18.12M | -4.61% | 64,824 | 11.41M |
| 511 | FBLG | FibroBiologics, Inc. | 17.83M | -5.76% | 784,629 | - |
| 512 | NERV | Minerva Neurosciences, Inc. | 17.55M | 6.81% | 73,522 | - |
| 513 | PULM | Pulmatrix, Inc. | 17.47M | 0.30% | 8,620 | 369.00K |
| 514 | BLRX | BioLineRx Ltd. | 17.47M | -2.30% | 13,624 | 17.25M |
| 515 | CMMB | Chemomab Therapeutics Ltd. | 17.41M | 2.59% | 199,532 | - |
| 516 | EDSA | Edesa Biotech, Inc. | 17.38M | -0.80% | 18,194 | - |
| 517 | NXTC | NextCure, Inc. | 17.31M | -2.71% | 6,503 | - |
| 518 | THAR | Tharimmune, Inc. | 17.22M | -2.01% | 158,771 | - |
| 519 | GLTO | Galecto, Inc. | 16.89M | 0.71% | 127,991 | - |
| 520 | LGVN | Longeveron Inc. | 16.85M | -1.55% | 355,753 | 2.07M |
| 521 | LPCN | Lipocine Inc. | 16.80M | - | 3,142 | 4.21M |
| 522 | GOVX | GeoVax Labs, Inc. | 15.81M | -4.16% | 696,936 | 6.14M |
| 523 | PHGE | BiomX Inc. | 15.79M | 1.75% | 286,176 | - |
| 524 | ASBP | Aspire Biopharma Holdings, Inc. | 15.75M | -3.69% | 1,213,396 | - |
| 525 | IBIO | iBio, Inc. | 15.70M | 0.95% | 184,914 | 400.00K |
| 526 | ICU | SeaStar Medical Holding Corporation | 15.63M | -2.03% | 883,880 | 766.00K |
| 527 | BCDA | BioCardia, Inc. | 15.49M | 8.96% | 331,181 | 3.00K |
| 528 | CLRB | Cellectar Biosciences, Inc. | 15.00M | 1.29% | 30,948 | - |
| 529 | INTS | Intensity Therapeutics, Inc. | 14.83M | -0.75% | 4,796,540 | - |
| 530 | IMRN | Immuron Limited | 14.65M | 0.48% | 33,581 | 4.78M |
| 531 | BIVI | BioVie Inc. | 14.43M | 4.64% | 132,704 | - |
| 532 | ABP | Abpro Holdings, Inc. | 14.40M | -2.39% | 934,163 | 183.00K |
| 533 | CANF | Can-Fite BioPharma Ltd. | 14.39M | -2.81% | 157,610 | 560.00K |
| 534 | SNSE | Sensei Biotherapeutics, Inc. | 14.37M | 1.15% | 908 | - |
| 535 | ATHA | Athira Pharma, Inc. | 14.36M | -4.21% | 45,223 | - |
| 536 | SNGX | Soligenix, Inc. | 14.19M | 1.19% | 395,134 | 2.34K |
| 537 | BRTX | BioRestorative Therapies, Inc. | 14.02M | - | 28,971 | 605.20K |
| 538 | DWTX | Dogwood Therapeutics, Inc. | 14.01M | 13.78% | 61,736 | - |
| 539 | COCP | Cocrystal Pharma, Inc. | 13.69M | -8.70% | 301,695 | - |
| 540 | PLRZ | Polyrizon Ltd. | 13.68M | 3.12% | 258,894 | - |
| 541 | XTLB | XTL Biopharmaceuticals Ltd. | 12.87M | 0.71% | 209,776 | 451.00K |
| 542 | MRKR | Marker Therapeutics, Inc. | 12.77M | -2.32% | 220,074 | 5.39M |
| 543 | LYRA | Lyra Therapeutics, Inc. | 12.66M | 0.39% | 23,556 | 770.00K |
| 544 | IMNN | Imunon, Inc. | 12.60M | -1.22% | 52,019 | - |
| 545 | PHIO | Phio Pharmaceuticals Corp. | 12.60M | -0.09% | 39,263 | - |
| 546 | AEON | AEON Biopharma, Inc. | 12.57M | -4.45% | 377,751 | - |
| 547 | OSRH | OSR Holdings, Inc. | 12.36M | 3.19% | 110,979 | 104.74K |
| 548 | ACXP | Acurx Pharmaceuticals, Inc. | 11.86M | 3.88% | 158,095 | - |
| 549 | MBIO | Mustang Bio, Inc. | 11.65M | 5.23% | 91,374 | - |
| 550 | RNAZ | TransCode Therapeutics, Inc. | 11.58M | -1.80% | 55,340 | - |
| 551 | NCNA | NuCana plc | 11.35M | 11.63% | 345,888 | - |
| 552 | EVGN | Evogene Ltd. | 11.30M | -0.34% | 18,903 | 9.44M |
| 553 | APM | Aptorum Group Limited | 11.22M | -5.42% | 375,371 | - |
| 554 | BOLT | Bolt Biotherapeutics, Inc. | 11.08M | -0.52% | 6,412 | 4.17M |
| 555 | KALA | KALA BIO, Inc. | 10.25M | 2.10% | 188,793 | - |
| 556 | MTNB | Matinas BioPharma Holdings, Inc. | 10.11M | 6.43% | 24,882 | - |
| 557 | ARTL | Artelo Biosciences, Inc. | 9.99M | -9.98% | 126,632 | - |
| 558 | INAB | IN8bio, Inc. | 9.67M | 1.43% | 17,062 | - |
| 559 | ERNA | Ernexa Therapeutics Inc. | 9.67M | -2.70% | 34,884 | 488.00K |
| 560 | VYNE | VYNE Therapeutics Inc. | 9.46M | 0.41% | 1,869,376 | 476.00K |
| 561 | KPRX | Kiora Pharmaceuticals, Inc. | 9.46M | 2.06% | 13,485 | 20.00K |
| 562 | HCWB | HCW Biologics Inc. | 8.89M | 1.72% | 56,542 | 832.84K |
| 563 | CELZ | Creative Medical Technology Holdings, Inc. | 8.72M | 1.50% | 8,610 | 6.00K |
| 564 | APRE | Aprea Therapeutics, Inc. | 8.65M | 4.58% | 40,672 | 841.01K |
| 565 | QNRX | Quoin Pharmaceuticals, Ltd. | 8.56M | -29.02% | 636,585 | - |
| 566 | GNPX | Genprex, Inc. | 8.49M | -3.53% | 2,670,548 | - |
| 567 | XBIO | Xenetic Biosciences, Inc. | 8.48M | -13.11% | 252,683 | 2.45M |
| 568 | ENTO | Entero Therapeutics, Inc. | 8.42M | 1.15% | 134,014 | - |
| 569 | SILO | Silo Pharma, Inc. | 8.38M | 11.92% | 254,567 | 72.10K |
| 570 | ADXN | Addex Therapeutics Ltd | 8.29M | -3.60% | 1,335 | 210.35K |
| 571 | ADIL | Adial Pharmaceuticals, Inc. | 8.23M | -1.13% | 182,712 | - |
| 572 | VIVS | VivoSim Labs, Inc. | 7.85M | -0.66% | 26,670 | 142.00K |
| 573 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.80M | 6.63% | 19,858 | 19.51K |
| 574 | GLMD | Galmed Pharmaceuticals Ltd. | 7.78M | - | 24,984 | - |
| 575 | ALZN | Alzamend Neuro, Inc. | 7.64M | 1.83% | 60,409 | - |
| 576 | KZIA | Kazia Therapeutics Limited | 7.63M | -2.15% | 6,966 | 1.55M |
| 577 | CYCN | Cyclerion Therapeutics, Inc. | 7.51M | 0.57% | 15,018 | 2.17M |
| 578 | IBO | Impact BioMedical Inc. | 7.43M | -0.96% | 62,530 | 7.00K |
| 579 | NLSP | NLS Pharmaceutics AG | 7.14M | -2.27% | 62,827 | - |
| 580 | QLGN | Qualigen Therapeutics, Inc. | 7.14M | 1.20% | 79,215 | - |
| 581 | TCRT | Alaunos Therapeutics, Inc. | 7.10M | -7.47% | 107,888 | 6.00K |
| 582 | NBY | NovaBay Pharmaceuticals, Inc. | 7.03M | -4.88% | 159,453 | 9.78M |
| 583 | PMCB | PharmaCyte Biotech, Inc. | 6.67M | -1.85% | 7,133 | - |
| 584 | JAGX | Jaguar Health, Inc. | 6.64M | -0.97% | 26,721 | 11.81M |
| 585 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 6.57M | 2.56% | 64,974 | 984.49K |
| 586 | PTIX | Protagenic Therapeutics, Inc. | 6.51M | 1.48% | 38,934 | - |
| 587 | ENSC | Ensysce Biosciences, Inc. | 6.50M | -2.67% | 76,292 | 7.41M |
| 588 | CLDI | Calidi Biotherapeutics, Inc. | 6.40M | 2.58% | 97,405 | - |
| 589 | PPBT | Purple Biotech Ltd | 6.05M | 4.37% | 326,090 | - |
| 590 | ONCO | Onconetix, Inc. | 5.61M | -0.55% | 19,664 | 1.33M |
| 591 | KTTA | Pasithea Therapeutics Corp. | 5.58M | -0.04% | 32,522 | - |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 5.40M | -3.25% | 10,880 | - |
| 593 | OGEN | Oragenics, Inc. | 5.37M | - | 48,175 | - |
| 594 | APVO | Aptevo Therapeutics Inc. | 5.23M | 1.27% | 1,373,293 | - |
| 595 | CMND | Clearmind Medicine Inc. | 5.10M | 0.17% | 42,021 | - |
| 596 | BDRX | Biodexa Pharmaceuticals Plc | 4.91M | -13.82% | 70,123 | 104.90K |
| 597 | XRTX | XORTX Therapeutics Inc. | 4.65M | -1.76% | 31,484 | - |
| 598 | GRI | GRI Bio, Inc. | 4.60M | -1.61% | 81,506 | - |
| 599 | INDP | Indaptus Therapeutics, Inc. | 4.45M | 2.70% | 116,151 | - |
| 600 | TOVX | Theriva Biologics, Inc. | 4.28M | -3.84% | 579,331 | - |
| 601 | ENVB | Enveric Biosciences, Inc. | 4.18M | 7.62% | 92,053 | - |
| 602 | CERO | CERo Therapeutics Holdings, Inc. | 4.06M | 1.81% | 350,200 | - |
| 603 | ELAB | PMGC Holdings Inc. | 3.51M | -5.12% | 33,076 | -605.53K |
| 604 | MLEC | Moolec Science SA | 3.21M | 0.06% | 212,152 | 7.83M |
| 605 | REVB | Revelation Biosciences, Inc. | 3.15M | -5.28% | 181,851 | - |
| 606 | VRAX | Virax Biolabs Group Limited | 2.87M | 1.40% | 135,502 | 6.33K |
| 607 | DRMA | Dermata Therapeutics, Inc. | 2.84M | 0.48% | 33,201 | - |
| 608 | GTBP | GT Biopharma, Inc. | 2.55M | 5.62% | 553,826 | - |
| 609 | ADTX | Aditxt, Inc. | 2.55M | -14.65% | 1,451,737 | 12.05K |
| 610 | AZTR | Azitra, Inc. | 2.49M | 2.54% | 127,516 | 7.50K |
| 611 | SLXN | Silexion Therapeutics Corp | 2.10M | -3.23% | 44,174 | - |
| 612 | SLRX | Salarius Pharmaceuticals, Inc. | 2.05M | -1.47% | 347,318 | - |
| 613 | PBM | Psyence Biomedical Ltd. | 2.04M | -2.91% | 54,047 | - |
| 614 | SCNI | Scinai Immunotherapeutics Ltd. | 2.04M | -1.46% | 42,116 | 1.15M |
| 615 | SPRC | SciSparc Ltd. | 1.83M | -14.71% | 178,944 | 1.31M |
| 616 | CDT | CDT Equity Inc. | 1.53M | - | 157,199 | - |